-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NasdaqUSDISIN US04335A1051
ISIN US04335A1051
WKN A2N6VP
Symbol ARVN
Währung
USD
Börse
Nasdaq Zeitzone: America/New_York
Firmenname
Arvinas, Inc
Marktkapitalisierung
3.242.840.608 (+- 20%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
3.904.681.216 oder 2.581.000.000
Mitarbeiter
274 (+- 51%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
133 oder 415 Mitarbeiter
EBITDA -64.270.736
PEGRatio None
Buchwert 5.116
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 63,01 USD -5,50%
Portrait der Arvinas Aktie
Das Unternehmen Arvinas, Inc aus USA beschäftigt 274 Mitarbeiter.
Das Unternehmen Arvinas, Inc ist nur in 6 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Arvinas mit 0,35% im ETF.
6 ETFs die in Arvinas investieren
Dir gefallen die Informationen zu Arvinas?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Arvinas?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Arvinas?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Arvinas?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
26 News & Informationen zur Arvinas Aktie
American Airlines Group Inc Ranked Among Today’s Top Shorts As Investors Await The Fed’s Talk On Tapering
The Dow Jones gained 65 points, while the S&P 500 and Nasdaq each gained 0.2%. Find opportunities in this market with the best short plays from Q.ai's deep learning algorithms.
Pfizer's Covid Technology May Have Cancer Applications
GuruFocus Article or News written by Barry Cohen and the topic is about: The mRNA-produced vaccines are now being tested in lung and breast cancers
Pfizer to acquire cancer drugmaker Trillium for $2.3 billion
It invested $25 million in Trillium in September as part of its ‘Breakthrough Growth Initiative’
Amyris Inc Among Today’s Top Shorts As Major Indices Fall Following The Fed’s Meeting Minutes
The Dow Jones dropped around 145 points or 0.4%, the S&P 500 fell 0.4%, and the Nasdaq dipped 0.5%. Find opportunities in today's market with today's best short plays from Q.ai's artificial intelligence.
Carvana Co Ranked Among Today’s Top Shorts
Markets were in the red this morning by just shy of 1% across the board. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
Arvinas Inc Ranked Among Today’s Top Shorts
Markets were slightly lower this morning after the Dow Jones touched all-time highs at the open. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
Arvinas Inc Ranked Among Today’s Top Shorts
The Dow Jones rose 10 points, while both the S&P 500 and Nasdaq also saw mild gains. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas
HONG KONG, Aug. 9, 2021 /PRNewswire/ — Insilico Medicine is proud to announce an R&D collaboration with Arvinas (NASDAQ: ARVN). This strategic pa…
Arvinas, Inc. (ARVN) Reports Q2 Loss, Tops Revenue Estimates
Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of -22.62% and 2.93%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Arvinas Inc (ARVN) CFO Sean A Cassidy Sold $1.7 million of Shares
GuruFocus Article or News written by insider and the topic is about:
Recent Price Trend in Arvinas, Inc. (ARVN) is Your Friend, Here's Why
Arvinas, Inc. (ARVN) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Analysts Estimate Arvinas, Inc. (ARVN) to Report a Decline in Earnings: What to Look Out for
Arvinas, Inc. (ARVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Were Hedge Funds Right About CNO Financial Group Inc (CNO)?
In this article we will take a look at whether hedge funds think CNO Financial Group Inc (NYSE:CNO) is a good investment right now. We check hedge fund…
75 Biggest Movers From Friday
Gainers The New Home Company Inc. (NYSE:NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired by funds managed…
Arvinas, Inc. (ARVN) Moves 13% Higher: Will This Strength Last?
Stocks Analysis by Zacks Investment Research covering: Pfizer Inc. Read Zacks Investment Research's latest article on Investing.com
Arvinas (ARVN), Pfizer Team up for Breast Cancer Therapy
Arvinas (ARVN) collaborates with Pfizer for its investigational breast cancer candidate, ARV-471. Pfizer is also set to acquire an equity stake in Arvinas. The stock rises 9% post the announcement.
DGAP-News: Il settore delle biotecnologie -2-
scienza. Il team di gestione di BB Biotech intende sfruttare questa tendenza in maniera mirata, ampliando le proprie
competenze negli ambiti di advanced analytics e intelligenza artificiale…. | July 23, 2021
Why Arvinas Jumped 10% Today
The smaller biopharma outfit just inked an encouraging deal with an industry powerhouse.
Arvinas Shares Rise 10% After Collaboration Deal With Pfizer
By Chris Wack
Arvinas Inc. shares were up 10% to $85.17 Thursday after the company said it and Pfizer Inc. entered into a global collaboration to develop and commercialize ARV-471, an… | July 22, 2021
Arvinas price target raised to a Street-high at Trust on Pfizer deal (NASDAQ:ARVN)
Truist Securities has boosted the price target of Arvinas <> to a Street-high citing the company’s agreement with Pfizer <> to jointly develop and commercialize the…
Pfizer, Arvinas Ink Deal To Develop And Commercialize PROTAC Protein Degrader ARV-471 – Quick Facts
(RTTNews) – Pfizer Inc. (PFE) and Arvinas, Inc. (ARVN) announced Thursday a global collaboration to develop and commercialize ARV-471, an investig…
Do Hedge Funds Love Ingevity Corporation (NGVT)?
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting…
Should I Avoid CNX Resources Corporation (CNX)?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed…
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 7) …
Stocks That Hit 52-Week Highs On Monday
During Monday’s morning session, 286 stocks hit new 52-week highs.
Areas of Interest: The company with the largest market cap to set a new …